Bailing Biology

Huadong Medicine Co., Ltd. (Stock Code: 000963) is one of China's Top 500 enterprises and a leading pharmaceutical enterprise in Zhejiang Province. The company is mainly engaged in the production and sales of antibiotics, traditional Chinese patent medicines, chemically synthesized drugs, and genetic engineering drugs, as well as the wholesale and retail distribution of Chinese and Western medicines, Chinese medicinal materials, and medical devices. It is a large comprehensive listed pharmaceutical company integrating pharmaceutical R&D, pharmaceutical manufacturing, pharmaceutical distribution, and pharmaceutical logistics, and undertakes the task of special drug reserves for national, provincial, and municipal governments. The company's business is mainly divided into two parts: pharmaceutical manufacturing and pharmaceutical commerce. The core of pharmaceutical manufacturing is its controlling subsidiary Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd., a national high-tech enterprise, an innovative enterprise, and one of China's Top 50 pharmaceutical manufacturing enterprises, and a domestic R&D and manufacturing enterprise of organ transplantation and diabetes drugs with a complete variety of products and leading production and sales volume. In the field of pharmaceutical commercial distribution, the company is a comprehensive large pharmaceutical commercial enterprise with leading scale and strength in Zhejiang Province, with business covering multiple formats such as direct sales to hospitals, commercial allocation, rapid drug wholesale, and terminal distribution.